Literature DB >> 16440417

Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.

Qian Guo1, Wei Tang, Yoshinori Inagaki, Yutaka Midorikawa, Norihiro Kokudo, Yasuhiko Sugawara, Munehiro Nakata, Toshiro Konishi, Hirokazu Nagawa, Masatoshi Makuuchi.   

Abstract

AIM: To assess subcellular localization of KL-6 mucin and its clinicopathological significance in colorectal carcinoma as well as metastatic lymph node and liver tissues.
METHODS: Colorectal carcinoma tissues as well as metastatic lymph node and liver tissues were collected from 82 patients who underwent colorectomy or hepatectomy. Tissues were subjected to immunohistochemical analysis using KL-6 antibody.
RESULTS: Of the 82 colorectal carcinoma patients, 6 showed no staining, 29 showed positive staining only in the apical membrane, and 47 showed positive staining in the circumferential membrane and/or cytoplasm. Positive staining was not observed in non-cancerous colorectal epithelial cells surrounding the tumor tissues. The five-year survival rate was significantly lower in cases showing positive staining in the circumferential membrane and/or cytoplasm (63.0%) than those showing positive staining only in the apical membrane (85.7%) and those showing no staining (100%). Statistical analysis between clinicopathological factors and subcellular localization of KL-6 mucin showed that KL-6 localization in the circumferential membrane and/or cytoplasm was significantly associated with the presence of venous invasion (P = 0.0003), lymphatic invasion (P<0.0001), lymph node metastasis (P<0.0001), liver metastasis (P = 0.058), and advanced histological stage (P<0.0001). Positive staining was observed in all metastatic lesions tested as well as in the primary colorectal carcinoma tissues.
CONCLUSION: The subcellular staining pattern of KL-6 in colorectal adenocarcinoma may be an important indicator for unfavorable behaviors such as lymph node and liver metastasis, as well as for the prognosis of patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440417      PMCID: PMC4077483          DOI: 10.3748/wjg.v12.i1.54

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Construction and characterization of a chimeric receptor containing the cytoplasmic domain of MUC1 mucin.

Authors:  D Meerzaman; P X Xing; K C Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-03       Impact factor: 5.464

2.  Studies on mechanism of Sialy Lewis-X antigen in liver metastases of human colorectal carcinoma.

Authors:  X W Li; Y Q Ding; J J Cai; S Q Yang; L B An; D F Qiao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  KL-6 mucin expression in carcinoma of the ampulla of Vater: association with cancer progression.

Authors:  Wei Tang; Yoshinori Inagaki; Norihiko Kokudo; Qian Guo; Yasuji Seyama; Munehiro Nakata; Hiroshi Imamura; Keiji Sano; Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

4.  The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas.

Authors:  J Lüttges; B Feyerabend; T Buchelt; M Pacena; G Klöppel
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

5.  Biosynthesis of MAM-6, an epithelial sialomucin. Evidence for involvement of a rare proteolytic cleavage step in the endoplasmic reticulum.

Authors:  J Hilkens; F Buijs
Journal:  J Biol Chem       Date:  1988-03-25       Impact factor: 5.157

Review 6.  The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature.

Authors:  J J Rahn; L Dabbagh; M Pasdar; J C Hugh
Journal:  Cancer       Date:  2001-06-01       Impact factor: 6.860

7.  Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.

Authors:  S J Gendler; C A Lancaster; J Taylor-Papadimitriou; T Duhig; N Peat; J Burchell; L Pemberton; E N Lalani; D Wilson
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

8.  DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion.

Authors:  H Kashiwagi; H Kijima; S Dowaki; Y Ohtani; K Tobita; M Tsukui; Y Tanaka; H Matsubayasi; T Tsuchida; H Yamazaki; M Nakamura; Y Ueyama; M Tanaka; T Tajima; H Makuuchi
Journal:  Int J Oncol       Date:  2000-03       Impact factor: 5.650

9.  Association of histochemical expression of Maackia amurensis leukoagglutinin-positive glycoconjugates with behaviour of human gastric cancer.

Authors:  W Tang; K Mafune; M Nakata; T Konishi; N Kojima; T Mizuochi; M Makuuchi
Journal:  Histopathology       Date:  2003-03       Impact factor: 5.087

10.  Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells.

Authors:  JoAnne Julian; Daniel D Carson
Journal:  Biochem Biophys Res Commun       Date:  2002-05-17       Impact factor: 3.575

View more
  7 in total

1.  Increased expression of mucinous glycoprotein KL-6 in human pterygium.

Authors:  S Kase; N Kitaichi; N Furudate; K Yoshida; S Ohno
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

2.  Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.

Authors:  Huan-Li Xu; Xin Zhao; Ke-Ming Zhang; Wei Tang; Norihiro Kokudo
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 3.  Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer.

Authors:  Yoshinori Inagaki; Jianjun Gao; Peipei Song; Norihiro Kokudo; Munehiro Nakata; Wei Tang
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 4.  MUC1 and metastatic cancer: expression, function and therapeutic targeting.

Authors:  Teresa M Horm; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

Review 5.  MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies.

Authors:  Yunhui Zeng; Qiongwen Zhang; Yujie Zhang; Minxun Lu; Yang Liu; Tianying Zheng; Shijian Feng; Meiqin Hao; Huashan Shi
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

6.  Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.

Authors:  Sabine Heublein; Doris Mayr; Markus Egger; Uwe Karsten; Steffen Goletz; Martin Angele; Julia Gallwas; Udo Jeschke; Nina Ditsch
Journal:  J Exp Clin Cancer Res       Date:  2015-05-19

7.  Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.

Authors:  Chao Li; Tao Liu; Libin Yin; Didi Zuo; Yuyang Lin; Lei Wang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.